View as Webpage

May 2025 | Weekly Digest robot


Cell and Gene

Therapy Solutions


556d2e98-8352-4e8d-9661-267fc3bfa2d6 image

Check out our personalized, featured highlights in this week's digest, including:



Keep reading to learn more!

INDUSTRY NEWS | Recombinant Factor C Assay

USP <86> Now Official — A Breakthrough in Endotoxin Detection with rFC Method

Exciting news for endotoxin testing: Recombinant Factor C (rFC) has been formally recognized in USP <86> as an official alternative to the traditional LAL assay—a landmark advancement in sustainable, animal-free endotoxin testing. By delivering robust and reproducible quality control results, the rFC method sets a new standard for both scientific rigor and environmental responsibility.

Explore rFC Endotoxin Detection

INDUSTRY NEWS|Residues Detection Kits

resDetect™: Comprehensive Kits for Residual Detection in Biopharmaceuticals

resDetect™ reagent kits are designed to meet international legal and regulatory standards for detecting residual components in biopharmaceutical manufacturing. Ideal for antibody drugs, cell and gene therapies (CGT), and vaccines, these kits effectively detect process-related residual substances such as host cell DNA, tool enzymes, antibiotics, protein A and dsRNA. Comprehensive solutions are available to support your quality control efforts.

FEATURED PRODUCTS | Residual Cytokine & Antibody

High-Sensitivity Assays for Residual Cytokine and Antibody Control

In cell therapy manufacturing, residual cytokines and antibodies like IL-2, IL-15, IL-7, and the monoclonal antibody OKT3 must be tightly controlled. Our comprehensive resDetect™ assay kits offer exceptional sensitivity and specificity, supporting CMC quality control and regulatory compliance with USP <1043> and other standards.

Related Hot Products


  • Human Interleukin-2 (IL-2) ELISA Kit
  • Human Interleukin-15 (IL-15) ELISA Kit
  • Anti-CD3 Antibody ELISA Kit